About CCBR - Czech Brno, s.r.o..
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at CCBR - Czech Brno, s.r.o..
During the past decade, CCBR - Czech Brno, s.r.o.. conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 7 clinical trials were completed, i.e. on
average, 140% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 3 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
The Evaluation of Bococizumab (PF-04950615;RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects
2013-10-29
2017-03-22
Terminated
16,784
The Evaluation of Bococizumab (PF-04950615; RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects
2013-10-29
2017-04-03
Terminated
10,564
A Study of PF-06438179 (Infliximab-Pfizer) and Infliximab in Combination With Methotrexate in Subjects With Active Rheumatoid Arthritis (REFLECTIONS B537-02).
2014-08-26
2017-06-01
Completed
650
Phase 3 Study of M923 and Humira® in Subjects With Chronic Plaque-type Psoriasis
2015-09-01
2017-04-04
Completed
572
Clinical Study to Evaluate the Efficacy, Safety and Immunogenicity of an MF59-Adjuvanted Quadrivalent Influenza Vaccine Compared to Non-influenza Vaccine Comparator in Adults ≥ 65 Years of Age
2016-09-30
2018-07-23
Completed
6,790
Efficacy and Safety of Vedolizumab Subcutaneous (SC) as Maintenance Therapy in Crohn's Disease (CD)
2016-01-04
2019-08-06
Completed
644
A Study of Long-term Effects of Vedolizumab Subcutaneous in Adults With Ulcerative Colitis and Crohn's Disease
2016-04-15
2023-05-06
Active, not recruiting
746
A Phase 4 Safety and Efficacy Study to Evaluate Lesinurad 200 mg in Participants With Gout and Renal Impairment
2017-07-19
2019-02-25
Terminated
242
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "CCBR - Czech Brno, s.r.o.." #1 sponsor was "Pfizer" with 3 trials, followed by "Takeda" with 2 trials
sponsored, "Ironwood Pharmaceuticals, Inc." with 1 trials sponsored, "Momenta Pharmaceuticals, Inc." with 1 trials sponsored and "Seqirus"
with 1 trials sponsored. Other sponsors include -5 different institutions and
companies that sponsored additional 5 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "CCBR - Czech Brno, s.r.o.."
#1 collaborator was "Medpace, Inc." with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at CCBR - Czech Brno, s.r.o..
According to Clinical.Site data, the most researched conditions in "CCBR - Czech Brno, s.r.o.." are
"Cardiovascular Disease" (2 trials), "Crohn's Disease" (2 trials), "Chronic Kidney Disease (CKD)" (1 trials), "Chronic Plaque Psoriasis" (1 trials) and "Colitis, Ulcerative" (1 trials). Many other conditions were trialed in "CCBR - Czech Brno, s.r.o.." in a lesser frequency.
Clinical Trials Intervention Types at CCBR - Czech Brno, s.r.o..
Most popular intervention types in "CCBR - Czech Brno, s.r.o.." are "Drug" (5 trials) and "Biological" (3 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (4 trials), "bococizumab (PF-04950615)" (2 trials), "Humira" (1 trials), "Infliximab" (1 trials) and "Lesinurad" (1 trials). Other intervention names were less common.
Clinical Trials Genders at CCBR - Czech Brno, s.r.o..
The vast majority of trials in "CCBR - Czech Brno, s.r.o.." are
8 trials for "All" genders.
Clinical Trials Status at CCBR - Czech Brno, s.r.o..
Currently, there are NaN active trials in "CCBR - Czech Brno, s.r.o..".
undefined are not yet recruiting,
undefined are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 4 completed trials in CCBR - Czech Brno, s.r.o..,
undefined suspended trials,
and 3 terminated clinical trials to date.
Out of the total trials that were conducted in CCBR - Czech Brno, s.r.o.., 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 7 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 0 trials that are defined as “Not Applicable".